Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring

Mainie, I.; Tutuian, R.; Shay, S.; Vela, M.; Zhang, X.; Sifrim, D.; Castell, D. O.
October 2006
Gut;Oct2006, Vol. 55 Issue 10, p1398
Academic Journal
Background and aims: Empiric proton pump inhibitor (PPI) trials have become increasingly popular leading to gastroenterologists frequently evaluating gastro-oesophageal reflux disease (GORD) patients only after they have ‘failed’ PPI therapy. Combined multichannel intraluminal impedance and pH (MII-pH) monitoring has the ability to detect gastro-oesophageal reflux (GOR) episodes independent of their pH and evaluate the relationship between symptoms and all types of GOR. Using this technique, we aimed to characterise the frequency of acid and non-acid reflux (NAR) and their relationship to typical and atypical GOR symptoms in patients on PPI therapy. Methods: Patients with persistent GORD symptoms referred to three centres underwent 24 hour combined MII-pH monitoring while taking PPIs at least twice daily. Reflux episodes were detected by impedance channels located 3, 5, 7, 9, 15, and 17 cm above the lower oesophageal sphincter (LOS) and classified into acid or non-acid based on pH data from 5 cm above the LOS. A positive symptom index (SI) was declared if at least half of each specific symptom events were preceded by reflux episodes within five minutes. Results: A total of 168 patients (103 (61%) females and 65 (39%) males; mean age 53 (range 18–85) years) underwent combined MII-pH monitoring while taking PPIs at least twice daily. One hundred and forty four (86%) patients recorded symptoms during the study day and 24 (15%) patients had no symptoms during testing. Sixty nine (48%) symptomatic patients had a positive SI for at least one symptom (16 (11%) with acid reflux and 53 (37%) with NAR) and 75 (52%) had a negative SI. A total of 171 (57%) typical GORD symptoms were recorded, 19 (11%) had a positive SI for acid reflux, 52 (31%) for NAR, and 100 (58%) had a negative SI. One hundred and thirty one (43%) atypical symptoms were recorded, four (3%) had a positive SI for acid reflux, 25 (19%) had a positive SI for NAR, and 102 (78%) had a negative SI. Conclusion: Combined MII-pH identifies the relation of reflux of all types to persistent symptoms and the importance of NAR in patients taking PPIs.


Related Articles

  • Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. Iwakiri, Katsuhiko; Kawami, Noriyuki; Sano, Hirohito; Tanaka, Yuriko; Umezawa, Mariko; Kotoyori, Makoto; Hoshihara, Yoshio; Sakamoto, Choitsu // Journal of Gastroenterology;2009, Vol. 44 Issue 7, p708 

    Combined multi-channel intra-luminal impedance and pH (Mll-pH) monitoring can detect gastro-esophageal reflux and identify acid and non-acid reflux (NAR) events. It can be used for patients with persistent symptoms who are having proton pump inhibitor (PPI) therapy. The aim of this study is to...

  • Acid Inhibition in GERD–How Much is Enough? Achem, Sami R. // American Journal of Gastroenterology;Jun2004, Vol. 99 Issue 6, p997 

    Gastric acid plays a fundamental role in the development of mucosal injury and symptoms in gastro-esophageal reflux disease(GERD). In this issue of theJournal, Milkes et al report the inability of proton pump inhibitor (PPIs) therapy to“normalize” 24-hour intraesophageal pH...

  • Got GERD? Dietary Changes Can Ease the Burn.  // Women's Nutrition Connection;Mar2016, Vol. 19 Issue 3, p1 

    The article discusses some dietary changes that can be adopted by people with gastroesophageal reflux disease (GERD) or frequent heartburn to eliminate the need for proton pump inhibitors (PPI) medications. It cites other symptoms of GERD, foods and beverages that increase gastric secretions and...

  • Surgical outcome in gastro-esophageal reflux disease patients with inadequate response to proton pump inhibitors. Anvari, M.; Allen, C. // Surgical Endoscopy;Jul2003, Vol. 17 Issue 7, p1029 

    Laparoscopic fundoplication (LF) has been shown to be effective in treatment of patients with gastro-esophageal reflux disease (GERD) requiring long-term medical therapy. Its effectiveness in patients with poor response to proton pump inhibitors (PPIs) has been questioned. We prospectively...

  • Response to PPI Treatment May Not Confirm GERD. Sadovsky, Richard // American Family Physician;2/1/2005, Vol. 71 Issue 3, p568 

    Discusses research being done on the response to proton-pump inhibitors (PPI) treatment as a diagnostic test for uncomplicated gastroesophageal reflux disease (GERD). Reference to a study by M. E. Numans and colleagues, published in the April 6, 2004 issue of the journal "Annals of Internal...

  • How acid reflux happens. Chan, Lillian // Wellness Options;2006, Issue 25, p30 

    Explains how the body's natural defensive mechanisms protect individuals against stomach acid reflux. Information on how the lower esophageal sphincter prevents acid reflux; Factors involved in anti-reflux barrier; Protective strategies against gastroesophageal reflux disease and peptic...

  • Reproducibility of Proximal Probe pH Parameters in 24-Hour Ambulatory Esophageal pH Monitoring. Vaesi, Michael F.; Schroeder, Patrick L.; Richter, Joel E. // American Journal of Gastroenterology;May1997, Vol. 92 Issue 5, p825 

    Objectives: To assess the reproducibility and reliability of the proximal pH probe in detecting acid reflux into the proximal esophagus. Methods: Using dual probe ambulatory esophageal pH monitoring, we studied 32 subjects (11 healthy control subjects, 10 patients with distal esophageal acid...

  • Helicobacter pylori and Acid Peptic Disorders of the Esophagus: Is It Conceivable? Vicari, Joseph; Falk, Gary W.; Richter, Joel E. // American Journal of Gastroenterology;Jul1997, Vol. 92 Issue 7, p1097 

    Examines the possible relationships between Helicobacter pylori and acid-peptic disorders of the esophagus in patients with gastroesophageal reflux disease (GERD). Prevalence of GERD in the U.S.; Relationship between H. pylori and GERD; H. pylori and adenocarcinoma of the gastroesophageal junction.

  • Complete Elimination of Reflux Symptoms Does Not Guarantee Normalization of Intraesophageal Acid Reflux in Patients With Barrett's Esophagus. Ouatu-Lascar, Rodica; Triadafilopoulus, George // American Journal of Gastroenterology;May1998, Vol. 93 Issue 5, p711 

    Objective: Normalization of intraesophageal acid exposure is increasingly recognized as a desired goal in the management of Barrett's esophagus. In this prospective trial, we studied patients with Barrett's esophagus by 24-h intraesophageal pH monitoring after having completely criminated their...


Read the Article


Sign out of this library

Other Topics